Stoke Therapeutics logo

Stoke Therapeutics

BrandBedford, MassachusettsWebsite

Company Overview

Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach.Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/.
Founded
2017
Headquarters
Bedford, Massachusetts
Employees
51-200
18% growth last 12mo
Marketing Team
7
4% of company

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Salaries

Job Posting Salary Data

From 1 marketing roles posted in the last 12 months

Typical Salary Range
$185,000$292,000
YEAR
100%
share salary

Community Salary Data

Help build salary transparency at Stoke Therapeutics. Share your compensation anonymously.

Contribute

Reviews

Jobs